A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease
| dc.contributor.author | McGhee, David J. M. | |
| dc.contributor.author | Ritchie, Craig W. | |
| dc.contributor.author | Zajicek, John P. | |
| dc.contributor.author | Counsell, Carl E. | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Chronic Disease Research Group | en |
| dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2016-06-17T11:40:07Z | |
| dc.date.available | 2016-06-17T11:40:07Z | |
| dc.date.issued | 2016-06-16 | |
| dc.description | Acknowledgements This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10124). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report or for the decision to submit for publication. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 13 | |
| dc.format.extent | 562321 | |
| dc.identifier | 67349397 | |
| dc.identifier | a254e3a3-e242-4d3b-b56a-14eb8056d2dd | |
| dc.identifier | 84975229879 | |
| dc.identifier.citation | McGhee, D J M, Ritchie, C W, Zajicek, J P & Counsell, C E 2016, 'A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease', BMC Neurology, vol. 16, 92, pp. 1-13. https://doi.org/10.1186/s12883-016-0606-3 | en |
| dc.identifier.doi | 10.1186/s12883-016-0606-3 | |
| dc.identifier.issn | 1471-2377 | |
| dc.identifier.other | ORCID: /0000-0001-6622-7839/work/164505725 | |
| dc.identifier.uri | http://hdl.handle.net/2164/6128 | |
| dc.identifier.vol | 16 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC Neurology | en |
| dc.subject | Alzheimer's disease | en |
| dc.subject | Parkinson's disease | en |
| dc.subject | disease progression | en |
| dc.subject | biomarkers | en |
| dc.subject | clinical trials | en |
| dc.subject | neuroprotective agents | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | RP-PG-0707-10124 | en |
| dc.subject.lcc | R | en |
| dc.title | A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease | en |
| dc.type | Journal article | en |